Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL)

Historical Holders from Q2 2018 to Q3 2025

Symbol
AUTL on Nasdaq
CUSIP
05280R100
Type / Class
Equity / Ordinary Shares, par value NIS 0.40 per share
Shares outstanding
23.6M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
166M
Holdings value
$378M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
93
Number of buys
51
Number of sells
-46
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Syncona Portfolio Ltd 10.8% $39.2M 28.8M Syncona Portfolio Limited Mar 31, 2025
MAK Capital Fund LP 5.8% $19.6M 15.4M MAK Capital Fund LP Jun 17, 2025
FMR LLC 3.8% $13.8M 10.2M FMR LLC Mar 31, 2025
ARMISTICE CAPITAL, LLC 4.99% $2.1M 1.18M Armistice Capital, LLC Jun 30, 2025

Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 490K $800K -$568K $1.63 2
2025 Q2 166M $378M +$9.84M $2.28 93
2025 Q1 168M $261M -$3.53M $1.55 94
2024 Q4 168M $395M -$37.1M $2.35 106
2024 Q3 179M $648M +$2.54M $3.63 97
2024 Q2 178M $619M -$54.4M $3.48 105
2024 Q1 176M $1.12B +$376M $6.38 114
2023 Q4 379K $2.48M +$1.19M $6.44 3
2023 Q3 111M $257M +$2.93M $2.33 66
2023 Q2 109M $260M +$12.4M $2.38 67
2023 Q1 106M $195M -$3.03M $1.84 63
2022 Q4 107M $204M +$110M $1.90 68
2022 Q3 49.2M $105M -$3.36M $2.14 60
2022 Q2 50.7M $144M -$7.12M $2.83 55
2022 Q1 45.5M $190M +$1.66M $4.17 58
2021 Q4 52.3M $272M +$102M $5.19 68
2021 Q3 25M $163M -$7.87M $6.55 56
2021 Q2 25.3M $169M +$23.3M $6.64 63
2021 Q1 22.3M $128M +$53M $5.73 57
2020 Q4 12.6M $113M +$4.28M $8.94 45
2020 Q3 12.4M $143M -$24.8M $11.64 44
2020 Q2 14.3M $229M -$16.4M $16.03 47
2020 Q1 16M $96.4M +$6.95M $5.99 48
2019 Q4 13.4M $177M +$26.8M $13.20 53
2019 Q3 13.4M $167M +$17.5M $12.42 42
2019 Q2 9.79M $158M +$59.9M $16.10 44
2019 Q1 18.1M $569M +$34M $31.47 32
2018 Q4 17M $558M -$24.1M $32.84 36
2018 Q3 17.9M $546M +$279M $30.66 39
2018 Q2 9.01M $238M +$234M $26.79 49